Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:47 PM
Ignite Modification Date:
2025-12-24 @ 7:47 PM
NCT ID:
NCT00191503
Eligibility Criteria:
Inclusion Criteria:
* Histologically proven adenocarcinoma
* No obvious primary on routine history, physical examination, and investigations
* Patients greater than or equal to 18 years of age
* ECOG Performance Status 0-1
* Patients requiring opioids for pain control must be on a fixed analgesic regimen aimed to provide adequate pain control with no more than 3 breakthrough (supplemental) doses of analgesics per day to control pain; Additional inclusion criteria due apply, but not are not listed here.
Exclusion Criteria:
* Have received treatment within the last 30 days with a drug that has not received regulatory approval for any indication at the time of study entry
* Unable to stabilize pain and analgesics for a period of 7 days prior to starting study treatment
* Prior treatment with chemotherapy
* Bilirubin greater than or equal to 40 mol/L
* AST or ALT greater than or equal to 5 times the upper limit of normal (ULN); Additional exclusion criteria due apply, but not are not listed here.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00191503
Study Brief:
Protocol Section:
NCT00191503